Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Assets Average (2021 - 2025)

Rani Therapeutics Holdings (RANI) has 5 years of Assets Average data on record, last reported at $13.5 million in Q3 2025.

  • For Q3 2025, Assets Average fell 69.02% year-over-year to $13.5 million; the TTM value through Sep 2025 reached $13.5 million, down 69.02%, while the annual FY2024 figure was $47.3 million, 43.02% down from the prior year.
  • Assets Average reached $13.5 million in Q3 2025 per RANI's latest filing, down from $20.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $130.6 million in Q4 2021 and bottomed at $13.5 million in Q3 2025.
  • Average Assets Average over 5 years is $74.6 million, with a median of $77.0 million recorded in 2023.
  • Peak YoY movement for Assets Average: decreased 0.81% in 2022, then plummeted 69.02% in 2025.
  • A 5-year view of Assets Average shows it stood at $130.6 million in 2021, then dropped by 17.21% to $108.1 million in 2022, then plummeted by 40.64% to $64.2 million in 2023, then crashed by 37.54% to $40.1 million in 2024, then crashed by 66.28% to $13.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $13.5 million in Q3 2025, $20.5 million in Q2 2025, and $30.4 million in Q1 2025.